Gold prices cool after hitting over 2-week high on Fed independence fears
Paul G. Moskowitz, a director and ten percent owner of Waystar Holding Corp. (NASDAQ:WAY), has sold a significant portion of his holdings in the company. According to a recent SEC filing, Moskowitz sold 5,652,689 shares of Waystar’s common stock at a price of $38.60 per share, totaling approximately $218.2 million. This transaction was part of a public offering that closed on February 24, 2025. The sale comes as Waystar’s stock has shown remarkable strength, delivering a 104.59% return over the past year. According to InvestingPro data, the company currently maintains a healthy liquidity position with a current ratio of 2.55.
The shares were sold by entities associated with Bain Capital, where Moskowitz is a partner. Following the transaction, Moskowitz retains indirect ownership of 22,327,728 shares. Additionally, a separate transaction involved the distribution of 573,192 shares to partners for charitable purposes, with no monetary exchange involved. With a market capitalization of $7.19 billion and trading near its 52-week high, InvestingPro analysis suggests the stock is currently overvalued. Subscribers can access 12 additional ProTips and a comprehensive Pro Research Report for deeper insights into Waystar’s financial health and growth prospects.
In other recent news, Waystar Holding Corp. reported robust financial results for the fourth quarter of 2024, with revenue reaching $244 million, marking an 18% increase compared to the same period last year. The company’s earnings per share exceeded forecasts, coming in at $0.29, and Waystar provided an optimistic revenue outlook for 2025, projecting growth between 7% and 10%. In addition to these financial achievements, Waystar has announced a public offering of 18 million shares by investment funds affiliated with EQT AB (ST:EQTAB), Canada Pension Plan Investment Board, and Bain Capital, LP. The offering will not financially benefit Waystar, as proceeds will go to the selling stockholders.
Analysts have responded positively to Waystar’s performance, with Canaccord Genuity, Goldman Sachs, and Evercore ISI all raising their price targets to $50 or more, while maintaining Buy or Outperform ratings. These upgrades are attributed to Waystar’s strong revenue growth, product innovation, and strategic acquisitions. Notably, Goldman Sachs highlighted Waystar’s outperformance in the fourth quarter, surpassing both revenue and profitability estimates.
Waystar’s ongoing product developments, including AI-driven solutions, have been well-received, with the company seeing increased interest from new clients following a cybersecurity incident affecting a competitor. The firm has maintained a net revenue retention rate of 110%, indicating successful expansion within its client base. These developments underscore Waystar’s strategic positioning in the healthcare technology market, as emphasized by analysts from Canaccord Genuity and Evercore ISI.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.